 NEW YORK, Jan. 17, 2023 GLOBE NEWSWIRE WHY: Rosen Law Firm, a global investor rights law firm, continues its investigation of potential securities claims on behalf of shareholders of Phathom Pharmaceuticals, Inc. NASDAQ: PHAT resulting from allegations that Phathom may have issued materially misleading business information to the investing public. SO WHAT: If you ... The post ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Phathom Pharmaceuticals, Inc. Investors to Inquire About Securities C... 